Diality
Diality is a medical device company developing the Moda-flx Hemodialysis System, a mobile, connected hemodialysis platform with integrated reverse osmosis water filtration, targeting acute care hospitals, skilled nursing facilities, chronic care clinics, and ultimately home dialysis patients.
- Company typePrivate
- Founded2018
- HeadquartersIrvine, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Diality does
Diality is a privately held medical device company headquartered in Irvine, California, developing the Moda-flx Hemodialysis System for the treatment of acute and chronic kidney disease. The platform integrates reverse osmosis water filtration with variable dialysate and blood flow rate capabilities, supporting treatment modalities ranging from sustained low-efficiency dialysis (SLED) through thrice-weekly in-center hemodialysis, packaged in a mobile form factor on a custom cart. A cloud-based data portal accompanies the device, enabling centralized treatment data capture and remote visibility across care settings.
The intended commercial model is B2B direct enterprise sales of capital equipment paired with recurring consumable cartridge revenue, targeting acute care hospitals, skilled nursing facilities, and chronic care clinics, with home dialysis pursued as a follow-on indication through the PRESCRIBE clinical trial. The Moda-flx system received FDA 510(k) clearance in August 2024 for professional care settings, with a limited market release targeted for 2027. Diality has raised approximately $82.5M across five funding rounds between 2018 and 2023, and operates with 11-50 employees under leadership combining clinical nephrology expertise (founder and CEO Osman Khawar, MD) with veteran dialysis industry operators on both the executive team and board.
The company remains pre-revenue as of the available data, with current activities centered on clinical trial execution, manufacturing partnership operations (Paramit), and pre-commercial organizational buildout including the recent CFO appointment.
Diality firmographics
Firmographics- Name
- Diality
- Legal name
- Diality, Inc.
- Website
- https://diality.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Diality is a medical device company developing the Moda-flx Hemodialysis System, a mobile, connected hemodialysis platform with integrated reverse osmosis water filtration, targeting acute care hospitals, skilled nursing facilities, chronic care clinics, and ultimately home dialysis patients.
- Ownership category
- akta.pro rank
Diality industry classification
Industry- Product category
- Hemodialysis Systems / Dialysis Medical Devices
- NAICS
- Kidney Dialysis Centers (621492)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodialysis Machines & Systems (HLAHAKAA)
- akta.pro secondary industries
- Continuous Renal Replacement Therapy (CRRT) & Acute Dialysis Systems (HLAHAKAF), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC)
Keywords
Where Diality is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Diality business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Hemodialysis System Sales: Diality generates revenue through the sale of its Moda-flx Hemodialysis System to healthcare facilities including hospitals, skilled nursing facilities, and clinics. The system includes capital equipment and single-use consumables (cartridges).
- Consumables and Accessories: Ongoing revenue from single-use cartridges required for each dialysis treatment session, providing a recurring consumables revenue stream.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Diality product offering
Product offeringCore offering
Diality develops and manufactures the Moda-flx Hemodialysis System, a mobile, connected hemodialysis platform with integrated reverse osmosis water filtration that enables on-demand dialysate generation from tap water. The system supports a broad range of prescriptions (IHD, SLED/SLEDD, PIRRT, and 3X weekly in-center treatments) and is intended for use in acute care hospitals, post-acute care facilities, chronic care settings, and (under IDE clinical trial) home use. Revenue is generated through capital equipment sales and recurring single-use consumable cartridges to healthcare facilities.
Product overview
Diality offers a single unified product: the Moda-flx Hemodialysis System. This hemodialysis platform is designed to empower healthcare professionals to choose personalized prescriptions for kidney disease patients across various care settings. The system features fully integrated reverse osmosis water filtration, prescription flexibility supporting treatments ranging from SLED to 3X weekly in-center treatments, and a cloud-based portal for data-driven clinical decisions.
Differentiator
Problem solved
Functional benefit
Brands
- Moda-flx: The Moda-flx Hemodialysis System is a hemodialysis platform designed to empower healthcare professionals to choose personalized hemodialysis prescriptions for patients' needs, featuring a fully integrated reverse osmosis water filtration system and an intuitive user interface designed to be easy to learn and use.
Products and services
- Moda-flx Hemodialysis System A mobile, connected hemodialysis platform for acute care hospitals, post-acute care facilities, chronic care settings, and (under IDE) home use, featuring integrated reverse osmosis water filtration, variable dialysate and blood flow rates, a cloud-based physician data portal, and an intuitive user interface enabling sub-4-hour training.
Quantifiable outcome
- Training time reduced to under 4 hours for new users
- +2 more outcomes
Companies that use Diality
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Diality technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Diality partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- aQua Research InstitutecoreDiality partnered with aQua Research Institute for the PRESCRIBE Diality Home Hemodialysis Clinical Trial. The institute serves as a clinical trial site for evaluating home use of the Moda-flx system by ESRD patients on stable dialysis regimens.
- aQua DialysiscoreaQua Dialysis in Houston, Texas is a clinical trial site partner for the PRESCRIBE Diality Home Hemodialysis Clinical Trial, treating the first patient in the home use evaluation of the Moda-flx system.
- North America Research Institute at Ontario-Holt Dialysis CentercoreFirst-ever patient treatment with the Moda-flx Hemodialysis System was completed in collaboration with North America Research Institute at Ontario-Holt Dialysis Center in Ontario, California, marking the initial clinical use of the system.
- Kidney Care PartnersminorDiality joined Kidney Care Partners, the nation's leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers. Membership provides networking and advocacy opportunities in the kidney care ecosystem.
- Paramit CorporationcoreDiality partnered with Paramit Corporation for the manufacture of its versatile hemodialysis system. The partnership was established to accelerate production and bring the system closer to market.
Scale indicators5 records
Recent moves6 records
Expansion highlights7 records
Diality competitors and assessment
Company assessmentDirect peers
- Outset Medical: Outset Medical's Tablo Hemodialysis System is the most direct competitor to Diality's Moda-flx: a next-generation, integrated water-purification, mobile hemodialysis platform marketed across acute, in-center, and home settings. Both target the same workflow-simplification and infrastructure-reduction thesis.
- Quanta Dialysis Technologies: Quanta's SC+ is a compact, portable hemodialysis system designed for flexibility across care settings including home use. Like Diality, Quanta targets the same underserved segments (SNF, home) with a simplified, mobile platform that challenges legacy in-center systems.
- NxStage Medical (Fresenius Renal Therapies): NxStage pioneered home hemodialysis with the System One and was acquired by Fresenius. Its home-hemodialysis-first design philosophy and adoption among home patients overlap directly with Diality's PRESCRIBE home trial strategy.
Broad incumbents
- Fresenius Medical Care: Fresenius is the global leader in dialysis products and services, having acquired NxStage Medical (home hemodialysis). It sells a broad portfolio of hemodialysis machines, dialyzers, and operates thousands of dialysis centers worldwide, directly competing with Diality on both device sales and downstream service economics.
- Baxter International (Vantive): Baxter's kidney care business (recently separated as Vantive) is a long-standing incumbent in hemodialysis systems, PD systems, and dialyzers. It serves the same hospital, in-center, and home dialysis customers as Diality and has the scale, GPO contracts, and installed base to defend share aggressively.
- Asahi Kasei Medical: Asahi Kasei is a leading global manufacturer of dialyzers and a broader renal-care portfolio. While not a direct machine-systems competitor, it is a major incumbent supplier to dialysis providers and serves overlapping nephrology customers.
- Nipro Corporation: Nipro is a significant manufacturer of dialyzers, dialysis machines, and related renal-care products, with growing presence in the U.S. dialysis market. It competes with Diality for hospital and clinic dialysis equipment spend.
Others
- Mar Cor Purification (Evoqua): Mar Cor is a leading provider of water purification systems for dialysis clinics — the very infrastructure Diality's integrated RO system is designed to displace. It is an adjacent/ecosystem competitor whose installed water rooms represent both an opportunity (retrofit) and a barrier (switching cost) for Diality.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Diality social profiles
Digital presenceDiality compliance and trust
Trust signalCompliance1 record
Diality financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diality leadership team
Management profileNumber of profiles
Profiles14 records
Diality funding detail
Funding detailFunding overview
Funding rounds5 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diality M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diality
What does Diality do?
Diality develops and manufactures the Moda-flx Hemodialysis System, a mobile, connected hemodialysis platform with integrated reverse osmosis water filtration that enables on-demand dialysate generation from tap water. The system supports a broad range of prescriptions (IHD, SLED/SLEDD, PIRRT, and 3X weekly in-center treatments) and is intended for use in acute care hospitals, post-acute care facilities, chronic care settings, and (under IDE clinical trial) home use. Revenue is generated through capital equipment sales and recurring single-use consumable cartridges to healthcare facilities.
Is Diality a public or private company?
Diality is a private company. It is classified as venture growth investor backed and is currently operating.
When was Diality founded?
Diality was founded in 2018. It employs 101 to 250 people.
Where is Diality based?
Diality is headquartered in Irvine, United States, in the North America region.
How does Diality make money?
Two revenue lines are on record. Hemodialysis System Sales are the primary driver. The others are consumables and Accessories.
Who are Diality's main competitors?
Direct peers on record are Outset Medical, Quanta Dialysis Technologies and NxStage Medical (Fresenius Renal Therapies). Broad incumbents are Fresenius Medical Care, Baxter International (Vantive), Asahi Kasei Medical and Nipro Corporation. Mar Cor Purification (Evoqua) is listed as an others.
Does Diality have an API?
No public API is recorded for Diality.
What industry is Diality in?
Diality's product category is Hemodialysis Systems / Dialysis Medical Devices. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAHAKAF, Continuous Renal Replacement Therapy (CRRT) & Acute Dialysis Systems. Its NAICS code is 621492 and its SIC code is 3841.